The investigation determined that false negative vitros hbsag results were obtained when tested using non-vitros external quality assessment (eqa) proficiency fluids when using vitros hbsag reagent lot 3460 on a vitros 3600 immunodiagnostic system.A definite assignable cause of the event cannot be determined.A potential contributor to the event was the calibration in use.A review of vitros hbsag reagent lot 3460 calibrations identified that the false negative vitros hbsag results were processed on a calibration that had expired 2 months prior.No precision testing was performed on the vitros 3600 immunodiagnostic system at the time of the event; therefore, an instrument related issue cannot be entirely ruled out as a contributor of the events.However, historical vitros qc fluid results were precise, and no evidence of any instrument malfunction was reported.The proficiency samples were from blood bags.Sample handling and storage of the proficiency samples is a possible contributor to the event as it was not determined if the customer was following the eqa ifu recommendation for sample handling and storage.Furthermore, the presence of an unknown sample interferent that affects the vitros hbsag method and not the non-vitros hbsag method cannot be ruled out as contributing to this event.The vitros hbsag ifu states ¿a negative test result does not exclude the possibility of exposure to or infection with hepatitis b virus.Levels of hbsag may be undetectable both in early infection and late after infection.In rare cases hbsag tests do not detect certain hbv mutant strains.
|